Professor Adil Al-Nahhas

Publications


Journals

  • de Geus-Oei L-F; Zerizer I; Uebleis C; Al-Nahhas A. (1 Feb 2012). Highlights of the EANM Congress 2011: Birmingham, UK. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 39:354-368. Author weblink DOI.
  • Evangelista L; Marzola MC; Chondrogiannis S; Al-Nahhas A; Rubello D. (27 Apr 2012). Colorectal cancer: translation of biological pathways into molecular imaging. Nucl Med Commun. DOI.
  • Maurice JB; Troke R; Win Z; Ramachandran R; Al-Nahhas A; Naji M; Dhillo W; Meeran K; et alGoldstone AP; Martin NM; Todd JF; Palazzo F; Tan T. (20 Apr 2012). A comparison of the performance of (68)Ga-DOTATATE PET/CT and (123)I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. DOI.
  • Naji M; AL-Nahhas A. (1 Feb 2012). Ga-68-labelled peptides in the management of neuroectodermal tumours. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 39:61-67. DOI.
  • Palomar A; Nanni C; Castellucci P; Ambrosini V; Montini GC; Allegri V; Pettinato C; Al-Nahhas A; et alSoriano A; Grassetto G; Rubello D; Fanti S. (1 Feb 2012). Value of FDG PET/CT in Patients with Treated Ovarian Cancer and Raised CA125 Serum Levels. MOLECULAR IMAGING AND BIOLOGY. 14:123-129. DOI.
  • Evangelista L; Cervino AR; Ghiotto C; Al-Nahhas A; Rubello D; Muzzio PC. (May 2012). Tumor Marker-Guided PET in Breast Cancer Patients-A Recipe for a Perfect Wedding: A Systematic Literature Review and Meta-Analysis. Clin Nucl Med. 37:467-474. DOI.
  • A L-Nahhas A; Fanti S. (Feb 2012). Radiolabelled peptides in diagnosis and therapy: an introduction. Eur J Nucl Med Mol Imaging. 39 Suppl 1:S1-S3. DOI.
  • Taieb D; Neumann H; Rubello D; Al-Nahhas A; Guillet B; Hindie E. (1 Feb 2012). Modern Nuclear Imaging for Paragangliomas: Beyond SPECT. JOURNAL OF NUCLEAR MEDICINE. 53:264-274. Author weblink DOI.
  • Marzola MC; De Manzoni G; Grassetto G; Cordiano C; Al-Nahhas A; Alavi A; Rubello D. (1 Jan 2012). Extended staging of oesophageal cancer using FDG-PET - A critical appraisal. EUROPEAN JOURNAL OF RADIOLOGY. 81:21-30. DOI.
  • Evangelista L; Nai Fovino L; Saladini F; Saladini G; Razzolini R; Mormino GP; Al-Nahhas A; Rubello D. (May 2012). Diagnostic and prognostic value of gated myocardial perfusion single-photon emission computed tomography in low-risk patients with left bundle-branch block. Nucl Med Commun. 33:491-497. DOI.
  • Mazza A; Rampin L; Montemurro D; Schiavon L; Zuin M; Grassetto G; Chondrogiannis S; Al-Nahhas A; et alRamazzina E; Rubello D. (1 Dec 2011). Renal scintigraphy predicts global cardiovascular risk in hypertensive subjects with normal serum creatinine levels. BLOOD PRESSURE. 20:387-393. Author weblink DOI.
  • Grassetto G; Groheux D; Marzola MC; Hindié E; Al-Nahhas A; Rubello D. (Jan 2012). FDG PET/CT in ovarian cancer: what about treatment response and prognosis?. Clin Nucl Med. 37:54-56. DOI.
  • Grassetto G; Fornasiero A; Otello D; Bonciarelli G; Rossi E; Nashimben O; Minicozzi AM; Crepaldi G; et alPasini F; Facci E; Mandoliti G; Marzola MC; Al-Nahhas A; Rubello D. (1 Dec 2011). (18)F-FDG-PET/CT in patients with breast cancer and rising Ca 15-3 with negative conventional imaging: A multicentre study. EUROPEAN JOURNAL OF RADIOLOGY. 80:828-833. Author weblink DOI.
  • De Iaco P; Musto A; Orazi L; Zamagni C; Rosati M; Allegri V; Cacciari N; Al-Nahhas A; et alRubello D; Venturoli S; Fanti S. (1 Nov 2011). FDG-PET/CT in advanced ovarian cancer staging: Value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy. EUROPEAN JOURNAL OF RADIOLOGY. 80:E98-E103. Author weblink DOI.
  • Chondrogiannis S; Grassetto G; Marzola MC; Rampin L; Massaro A; Bellan E; Ferretti A; Mazza A; et alAl-Nahhas A; Rubello D. (Feb 2012). 18F-DOPA PET/CT biodistribution consideration in 107 consecutive patients with neuroendocrine tumours. Nucl Med Commun. 33:179-184. DOI.
  • Contractor K; Challapalli A; Barwick T; Winkler M; Hellawell G; Hazell S; Tomasi G; Al-Nahhas A; et alMapelli P; Kenny LM; Tadrous P; Coombes RC; Aboagye EO; Mangar S. (15 Dec 2011). Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression. Clin Cancer Res. 17:7673-7683. DOI.
  • Contractor KB; Kenny LM; Stebbing J; Rosso L; Ahmad R; Jacob J; Challapalli A; Turkheimer F; et alAl-Nahhas A; Sharma R; Coombes RC; Aboagye EO. (15 Dec 2011). [18F]-3'Deoxy-3'-fluorothymidine positron emission tomography and breast cancer response to docetaxel. Clin Cancer Res. 17:7664-7672. DOI.
  • Mazza A; Beltramello G; Armigliato M; Montemurro D; Zorzan S; Zuin M; Rampin L; Marzola MC; et alGrassetto G; Al-Nahhas A; Rubello D. (1 Sep 2011). Arterial hypertension and thyroid disorders: What is important to know in clinical practice?. ANNALES D ENDOCRINOLOGIE. 72:296-303. DOI.
  • Wong KK; Arabi M; Zerizer I; Al-Nahhas A; Rubello D; Gross MD. (1 Sep 2011). Role of positron emission tomography/computed tomography in adrenal and neuroendocrine tumors: fluorodeoxyglucose and nonfluorodeoxyglucose tracers. NUCLEAR MEDICINE COMMUNICATIONS. 32:764-781. Author weblink DOI.
  • Fuccio C; Castellucci P; Marzola MC; Al-Nahhas A; Fanti S; Rubello D. (Oct 2011). Noninvasive and invasive staging of ovarian cancer: review of the literature. Clin Nucl Med. 36:889-893. DOI.
  • Grassetto G; Marzola MC; Minicozzi A; Al-Nahhas A; Rubello D. (Oct 2011). F-18 FDG PET/CT in rectal carcinoma: where are we now?. Clin Nucl Med. 36:884-888. DOI.
  • Al-Nahhas A. (Oct 2011). Detection of unsuspected bone metastases by ⁶⁸Ga-DOTA: nuclear medicine at the forefront again. Nucl Med Commun. 32:877-879. DOI.
  • Taieb D; Rubello D; Al-Nahhas A; Calzada M; Marzola MC; Hindie E. (1 Aug 2011). Modern PET imaging for paragangliomas: Relation to genetic mutations. EJSO. 37:662-668. DOI.
  • Contractor KB; Kenny LM; Stebbing J; Challapalli A; Al-Nahhas A; Palmieri C; Shousha S; Lewis JS; et alHogben K; De Nguyen Q; Coombes RC; Aboagye EO. (Nov 2011). Biological basis of [¹¹C]choline-positron emission tomography in patients with breast cancer: comparison with [¹⁸F]fluorothymidine positron emission tomography. Nucl Med Commun. 32:997-1004. DOI.
  • Wong KK; Arabi M; Zerizer I; Al-Nahhas A; Rubello D; Gross MD. (Sep 2011). Role of positron emission tomography/computed tomography in adrenal and neuroendocrine tumors: fluorodeoxyglucose and nonfluorodeoxyglucose tracers. Nucl Med Commun. 32:764-781. DOI.
  • Al-Nahhas A; Jawad AS. (Jun 2011). PET/CT imaging in inflammatory myopathies. Ann N Y Acad Sci. 1228:39-45. DOI.
  • Vyas NS; Patel NH; Nijran KS; Al-Nahhas A; Puri BK. (1 Jan 2011). The use of PET imaging in studying cognition, genetics and pharmacotherapeutic interventions in schizophrenia. EXPERT REVIEW OF NEUROTHERAPEUTICS. 11:37-51. Author weblink DOI.
  • Castellucci P; Fuccio C; Marzola MC; Al-Nahhas A; Rubello D; Fanti S. (Jun 2011). Prostate-specific antigen kinetics and choline PET/CT in patients with biochemical relapse after primary treatment for prostate cancer. Nucl Med Commun. 32:475-478. DOI.
  • Zerizer I; Parsaï A; Win Z; Al-Nahhas A. (Jun 2011). Anatomical and functional localization of ectopic parathyroid adenomas: 6-year institutional experience. Nucl Med Commun. 32:496-502. DOI.
  • Rubello D; Kapse N; Grassetto G; Massaro A; Al-Nahhas A. (1 Dec 2010). Minimally invasive radio-guided surgery for primary hyperparathyroidism: From preoperative to intraoperative localization imaging. ANNALES D ENDOCRINOLOGIE. 71:511-518. DOI.
  • Kenny LM; Al-Nahhas A; Aboagye EO. (May 2011). Novel PET biomarkers for breast cancer imaging. Nucl Med Commun. 32:333-335. DOI.
  • Zanotti-Fregonara P; Keller I; Calzada-Nocaudie M; Al-Nahhas A; Devaux J-Y; Grassetto G; Marzola MC; Rubello D; et alHindie E. (1 Dec 2010). Increased serum thyroglobulin levels and negative imaging in thyroid cancer patients: are there sources of benign secretion? A speculative short review. NUCLEAR MEDICINE COMMUNICATIONS. 31:1054-1058. DOI.
  • Liberatore M; Calandri E; Ciccariello G; Fioravanti M; Megna V; Rampin L; Marzola MC; Zerizer I; et alAl-Nahhas A; Rubello D. (1 Dec 2010). The Labeled-Leukocyte Scan in the Study of Abdominal Abscesses. MOLECULAR IMAGING AND BIOLOGY. 12:563-569. DOI.
  • Hodolic M; Fettich J; Banti E; Chondrogiannis S; Al-Nahhas A; Rubello D. (1 Sep 2010). Diagnostics of Neuroendocrine Tumours. IN VIVO. 24:771-774. Author weblink.
  • Salem S; Patel NH; Barwick T; Al-Nahhas A; Howard DJ; Zerizer I; Win Z. (1 Oct 2010). Occult Squamous Cell Carcinoma of the Uvula Detected by F-18 FDG PET/CT in a Case of Carcinoma of Unknown Primary in the Head and Neck. CLINICAL NUCLEAR MEDICINE. 35:800-801. DOI.
  • Kenny LM; Contractor KB; Hinz R; Stebbing J; Palmieri C; Jiang J; Shousha S; Al-Nahhas A; et alCoombes RC; Aboagye EO. (15 Aug 2010). Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumab. Clin Cancer Res. 16:4236-4245. DOI.
  • Naji M; Zhao C; Welsh SJ; Meades R; Win Z; Ferrarese A; Tan T; Rubello D; et alAl-Nahhas A. (Aug 2011). 68Ga-DOTA-TATE PET vs. 123I-MIBG in identifying malignant neural crest tumours. Mol Imaging Biol. 13:769-775. DOI.
  • Karunanithy N; Gordon F; Hodolic M; Al-Nahhas A; Wasan HS; Habib N; Tait NP. (Apr 2011). Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy. Cardiovasc Intervent Radiol. 34:287-294. DOI.
  • Vyas NS; Patel NH; Nijran KS; Al-Nahhas A; Puri BK. (1 Jul 2010). Insights into schizophrenia using positron emission tomography: building the evidence and refining the focus. BRITISH JOURNAL OF PSYCHIATRY. 197:3-4. Author weblink DOI.
  • Fuccio C; Castellucci P; Schiavina R; Santi I; Allegri V; Pettinato V; Boschi S; Martorana G; et alAl-Nahhas A; Rubello D; Fanti S. (1 Jul 2010). Role of C-11-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy. ANNALS OF NUCLEAR MEDICINE. 24:485-492. Author weblink DOI.
  • Marzola MC; Pelizzo MR; Ferdeghini M; Toniato A; Massaro A; Ambrosini V; Fanti S; Gross MD; et alAl-Nahhas A; Rubello D. (1 Apr 2010). Dual PET/CT with F-18-DOPA and F-18-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging. EJSO. 36:414-421. Author weblink DOI.
  • Bhate K; Mok WY; Tran K; Khan S; Al-Nahhas A. (Mar 2010). Functional assessment in the multimodality imaging of pancreatic neuro-endocrine tumours. Minerva Endocrinol. 35:17-25.
  • Al-Nahhas A. (May 2010). The new cover. Nucl Med Commun. 31:345. DOI.
  • Grassetto G; Fornasiero A; Bonciarelli G; Banti E; Rampin L; Marzola MC; Massaro A; Galeotti F; et alDel Favero G; Pasini F; Minicozzi AM; Al-Nahhas A; Cordiano C; Rubello D. (1 Apr 2010). Additional Value of FDG-PET/CT in Management of "Solitary" Liver Metastases: Preliminary Results of a Prospective Multicenter Study. MOLECULAR IMAGING AND BIOLOGY. 12:139-144. DOI.
  • Groheux D; Giacchetti S; Rubello D; Al-Nahhas A; Moretti J-L; Espie M; Hindie E. (1 Apr 2010). The evolving role of PET/CT in breast cancer. NUCLEAR MEDICINE COMMUNICATIONS. 31:271-273. DOI.
  • Patel NH; Vyas NS; Puri BK; Nijran KS; Al-Nahhas A. (Apr 2010). Positron emission tomography in schizophrenia: a new perspective. J Nucl Med. 51:511-520. DOI.
  • Hodolic M; Fettich J; Marzola MC; Tonini E; Al-Nahhas A; Rubello D. (1 Jan 2010). Radioguided Surgery and Systemic Radionuclide Therapy of Neuroendocrine Tumours. IN VIVO. 24:97-100.
  • Zerizer I; Tan K; Khan S; Barwick T; Marzola MC; Rubello D; Al-Nahhas A. (Mar 2010). Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis. Eur J Radiol. 73:504-509. DOI.
  • Gray KR; Contractor KB; Kenny LM; Al-Nahhas A; Shousha S; Stebbing J; Wasan HS; Coombes RC; et alAboagye EO; Turkheimer FE; Rosso L. (7 Feb 2010). Kinetic filtering of [(18)F]Fluorothymidine in positron emission tomography studies. Phys Med Biol. 55:695-709. DOI.
  • Vyas NS; Patel NH; Nijran KS; Al-Nahhas A; Puri BK. (Feb 2010). Can PET/CT imaging advance our understanding of the neurobiology of schizophrenia?. Nucl Med Commun. 31:91-93. DOI.
  • Shah S; Win Z; Al-Nahhas A. (1 Sep 2009). Multiorgan dysfunctions in diabetic patients: the role of functional imaging. MINERVA ENDOCRINOLOGICA. 34:223-236. Author weblink.
  • Kenny LM; Contractor KB; Stebbing J; Al-Nahhas A; Palmieri C; Shousha S; Coombes RC; Aboagye EO. (1 Nov 2009). Altered tissue 3'-deoxy-3'-[18F]fluorothymidine pharmacokinetics in human breast cancer following capecitabine treatment detected by positron emission tomography. Clin Cancer Res. 15:6649-6657. DOI.
  • Naji M; Hodolic M; El-Refai S; Khan S; Marzola MC; Rubello D; Al-Nahhas A. (Jan 2010). Endocrine tumors: the evolving role of positron emission tomography in diagnosis and management. J Endocrinol Invest. 33:54-60. DOI.
  • Ambrosini V; Castellucci P; Rubello D; Nanni C; Musto A; Allegri V; Montini GC; Mattioli S; et alGrassetto G; Al-Nahhas A; Franchi R; Fanti S. (1 Oct 2009). Ga-68-DOTA-TOC/NOC in bronchial carcinoids Reply. NUCLEAR MEDICINE COMMUNICATIONS. 30:822-823. Author weblink.
  • Maffione AM; Piva M; Tsamita CS; Nanni C; Castellucci P; Ambrosini V; Lopci E; Musto A; et alRampin L; Grassetto G; Marzola MC; Massaro A; Cracco E; Al-Nahhas A; Fanti S; Rubello D. (1 Oct 2009). Positron-emission tomography in gynaecologic malignancies. ARCHIVES OF GYNECOLOGY AND OBSTETRICS. 280:521-528. Author weblink DOI.
  • Contractor KB; Kenny LM; Stebbing J; Al-Nahhas A; Palmieri C; Sinnett D; Lewis JS; Hogben K; et alOsman S; Shousha S; Lowdell C; Coombes RC; Aboagye EO. (1 Sep 2009). [11C]choline positron emission tomography in estrogen receptor-positive breast cancer. Clin Cancer Res. 15:5503-5510. DOI.
  • Pagou M; Zerizer I; Al-Nahhas A. (May 2009). Can gallium-68 compounds partly replace (18)F-FDG in PET molecular imaging?. Hell J Nucl Med. 12:102-105.
  • Mazza A; Zamboni S; Zerizer I; Al-Nahhas A; Rubello D; Casiglia E. (1 Aug 2009). Anatomical or functional imaging in endocrine hypertension: competition or synergy?. NUCLEAR MEDICINE COMMUNICATIONS. 30:581-585. Author weblink DOI.
  • Sorgato N; Pennelli G; Boschin IM; Ide EC; Pagetta C; Piotto A; Toniato A; De Salvo GL; et alHindie E; Al-Nahhas A; Rubello D; Pelizzo MR. (1 May 2009). Can we Avoid Inadvertent Parathyroidectomy during Thyroid Surgery?. IN VIVO. 23:433-439. Author weblink.
  • Ambrosini V; Quarta C; Nanni C; Pettinato C; Franchi R; Grassetto G; Al-Nahhas A; Fanti S; et alRubello D. (1 Apr 2009). Small Animal PET in Oncology: The Road from Bench to Bedside. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 24:277-285. Author weblink DOI.
  • Lavender FM; Meades RT; Al-Nahhas A; Nijran KS. (1 May 2009). Factors affecting the measurement of left ventricular ejection fraction in myocardial perfusion imaging. NUCLEAR MEDICINE COMMUNICATIONS. 30:350-355. DOI.
  • Rizzello A; Di Pierro D; Lodi F; Trespidi S; Cicoria G; Pancaldi D; Nanni C; Marengo M; et alMarzola MC; Al-Nahhas A; Rubello D; Boschi S. (Jul 2009). Synthesis and quality control of 68Ga citrate for routine clinical PET. Nucl Med Commun. 30:542-545. DOI.
  • Ambrosini V; Castellucci P; Rubello D; Nanni C; Musto A; Allegri V; Montini GC; Mattioli S; et alGrassetto G; Al-Nahhas A; Franchi R; Fanti S. (1 Apr 2009). Ga-68-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid. NUCLEAR MEDICINE COMMUNICATIONS. 30:281-286. Author weblink DOI.
  • Sathekge M; Maes A; Al-Nahhas A; Rubello D; Chiti A. (1 Apr 2009). What impact can fluorine-18 fluorodeoxyglucose PET/computed tomography have on HIV/AIDS and tuberculosis pandemic?. NUCLEAR MEDICINE COMMUNICATIONS. 30:255-257. Author weblink DOI.
  • Nannini M; Pantaleo MA; Maleddu A; Al-Nahhas A; Rubello D; Fanti S; Biasco G. (1 Mar 2009). The Response Evaluation Criteria in Solid Tumors: until when?. NUCLEAR MEDICINE COMMUNICATIONS. 30:185-187. Author weblink DOI.
  • Khan S; Dunn J; Strickland N; Al-Nahhas A. (2008). Iodine-123 uptake in vertebral haemangiomas in a patient with papillary thyroid carcinoma. Nucl Med Rev Cent East Eur. 11:30-33.
  • Dunn J; Khan S; Ariff B; Strickland N; Al-Nahhas A. (2008). Pulmonary emboli and extramedullary haematopoiesis in beta-thalassaemia intermedia. Nucl Med Rev Cent East Eur. 11:34-36.
  • Khan S; Dunn J; Ariff B; Juli C; Karunanithy N; Strickland N; Al-Nahhas A. (2008). A rare combination of cardiopulmonary anomalies demonstrated on ventilation-perfusion scan. Nucl Med Rev Cent East Eur. 11:37-39.
  • Rubello D; Rampin L; Banti E; Grassetto G; Massaro A; Cittadin S; Pavan L; Cattelan AM; et alFanti S; Al-Nahhas A; Gross MD; Alavi A. (1 Nov 2008). Antigranulocyte scintigraphy in infected hip prosthesis: the diagnostic importance of delayed 20-24-h imaging and semiquantitative analysis. NUCLEAR MEDICINE COMMUNICATIONS. 29:994-998. Author weblink DOI.
  • Shah S; Win Z; Al-Nahhas A. (Sep 2008). Multimodality imaging of the parathyroid glands in primary hyperparathyroidism. Minerva Endocrinol. 33:193-202.
  • Harari OA; Al-Nahhas A; Jawad A. (1 Sep 2008). (18)F-fluorodeoxyglucose-positron emission tomography imaging in idiopathic inflammatory myositis. NUCLEAR MEDICINE COMMUNICATIONS. 29:838-840. Author weblink.
  • Lodi F; Rizzello A; Trespidi S; Di Pierro D; Marengo M; Farsad M; Fanti S; Al-Nahhas A; et alRubello D; Boschi S. (1 Aug 2008). Reliability and reproducibility of N-[C-11]methyl-choline and L-(S-methyl-[C-11])methionine solid-phase synthesis: a useful and suitable method in clinical practice. NUCLEAR MEDICINE COMMUNICATIONS. 29:736-740. Author weblink.
  • Khan S; Lloyd C; Szyszko T; Win Z; Rubello D; Al-Nahhas A. (1 Jun 2008). PET imaging in endocrine tumours. MINERVA ENDOCRINOLOGICA. 33:41-52. Author weblink.
  • Al-Nahhas A; Rubello D. (1 Jun 2008). Nuclear medicine in endocrinology. MINERVA ENDOCRINOLOGICA. 33:39-40. Author weblink.
  • Rubello D; Rampin L; Nanni C; Banti E; Ferdeghini M; Fanti S; Al-Nahhas A; Gross MD. (1 May 2008). The role of F-18-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: A prospective study. EJSO. 34:581-586. Author weblink DOI.
  • Szyszko T; Brooks A; Tait P; Rubello D; AL-Nahhas A. (Oct 2008). Therapy options for treatment of hepatic malignancy. Eur J Nucl Med Mol Imaging. 35:1824-1826. DOI.
  • Kenny LM; Coombes RC; Oulie I; Contractor KB; Miller M; Spinks TJ; McParland B; Cohen PS; et alHui AM; Palmieri C; Osman S; Glaser M; Turton D; Al-Nahhas A; Aboagye EO. (Jun 2008). Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients. J Nucl Med. 49:879-886. DOI.
  • Rufini V; Castaldi P; Treglia G; Perotti G; Gross MD; Al-Nahhas A; Rubello D. (1 Mar 2008). Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma. BIOMEDICINE & PHARMACOTHERAPY. 62:139-146. Author weblink DOI.
  • Khodjibekova M; Szyszko T; Khan S; Nijran K; Tait P; Al-Nahhas A. (Sep 2007). Selective internal radiation therapy with Yttrium-90 for unresectable liver tumours. Rev Recent Clin Trials. 2:212-216.
  • Ambrosini V; Rubello D; Nanni C; Al-Nahhas A; Fanti S. (1 May 2008). Ga-68-DOTA-peptides versus F-18-DOPA PET for the assessment of NET patients. NUCLEAR MEDICINE COMMUNICATIONS. 29:415-417. Author weblink DOI.
  • Soloviev D; Fini A; Chierichetti F; Al-Nahhas A; Rubello D. (1 May 2008). PET imaging with C-11-acetate in prostate cancer: a biochemical, radiochemical and clinical perspective. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 35:942-949. Author weblink DOI.
  • Khan S; Lloyd C; Szyszko T; Win Z; Rubello D; Al-Nahhas A. (Jun 2008). PET imaging in endocrine tumours. Minerva Endocrinol. 33:41-52.
  • Al-Nahhas A; Khan S; Gogbashian A; Banti E; Rampin L; Rubello D. (1 Jan 2008). F-18-FDG PET in the diagnosis and follow-up of thyroid malignancy. IN VIVO. 22:109-114. Author weblink.
  • Tartaglione G; Vigili MG; Rahimi S; Celebrini A; Pagan M; Lauro L; Al-Nahhas A; Rubello D. (1 Apr 2008). The impact of superficial injections of radiocolloids and dynamic lymphoscintigraphy on sentinel node identification in oral cavity cancer: a same-day protocol. NUCLEAR MEDICINE COMMUNICATIONS. 29:318-322. Author weblink.
  • Khodjibekova M; Szyszko T; Singh A; Tait P; Rubello D; Al-Nahhas A. (Dec 2007). Treatment of primary and secondary liver tumours with selective internal radiation therapy. J Exp Clin Cancer Res. 26:561-570.
  • Szyszko T; Nadarajah J; Khan S; Tait P; Wasan H; Habib N; Al-Nahhas A. (1 Sep 2006). Yttrium 90 microspheres in the treatment of hepatic metastases: a comparison of FDG-PET and CT imaging in assessment of response to treatment. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 33:S327-S327. Author weblink.
  • Vlajkovic M; Singh A; Saddadi F; Win Z; Nadarajah J; Al-Nahhas A. (1 Sep 2006). Clinical relevance of standardised uptake value in the detection of malignant liver lesions. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 33:S257-S257. Author weblink.
  • Win Z; Kahn S; Towey D; Rahman L; Murrell J; Al-Nahhas A. (1 Sep 2006). Ga-68-DOTATATE PET imaging in neuroectodermal tumours. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 33:S190-S190. Author weblink.
  • Tunariu N; Gibbs S; Win Z; Gin-Sing W; Graham A; Al-Nahhas A. (1 Sep 2006). V/Q scans are more sensitive than CTPA in detecting chronic pulmonary thromboembolic disease as a cause of Pulmonary Hypertension. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 33:S170-S170. Author weblink.
  • Rubello D; Rampin L; Banti E; Massaro A; Cittadin S; Cattelan AM; Al-Nahhas A. (Apr 2008). Diagnosis of infected total knee arthroplasty with anti-granulocyte scintigraphy: the importance of a dual-time acquisition protocol. Nucl Med Commun. 29:331-335. DOI.
  • Sebastian AJ; Szyszko T; Al-Nahhas A; Nijran K; Tait NP. (May 2008). Evaluation of hepatic angiography procedures and bremsstrahlung imaging in selective internal radiation therapy: a two-year single-center experience. Cardiovasc Intervent Radiol. 31:643-649. DOI.
  • Al-Nahhas A; Win Z; Szyszko T; Singh A; Nanni C; Fanti S; Rubello D. (Nov 2007). Gallium-68 PET: a new frontier in receptor cancer imaging. Anticancer Res. 27:4087-4094.
  • Rasulova N; Singh A; Demetriadou O; Georgiou G; Yiannakkaras C; Khodjibekov M; Al-Nahhas A. (Feb 2008). Clinical significance of myocardial perfusion abnormalities in patients with varying degree of coronary artery stenosis. Nucl Med Commun. 29:129-136. DOI.
  • Rubello D; Salvatori M; Ardito G; Mariani G; Al-Nahhas A; Gross MD; Muzzio PC; Pelizzo MR. (1 Sep 2007). Iodine-131 radio-guided surgery in differentiated thyroid cancer: Outcome on 31 patients and review of, the literature. BIOMEDICINE & PHARMACOTHERAPY. 61:477-481. Author weblink DOI.
  • Montesano T; Durante C; Attard M; Crocetti U; Meningolo D; Bruno R; Tumino S; Rubello D; et alAl-Nahhas A; Colandlea M; Maranghi M; TravasCio L; Ronga G; Torlontano M. (1 Sep 2007). Age influences TSH serum levels after withdrawal of 1-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer. BIOMEDICINE & PHARMACOTHERAPY. 61:468-471. DOI.
  • Rubello D; Salvatori M; Casara D; Piotto A; Toniato A; Gross MD; Al-Nahhas A; Muzzio PC; et alPelizzo MR. (1 Sep 2007). Tc-99m-sestamibi radio-guided surgery of loco-regional (131)Iodine-negative recurrent thyroid cancer. EJSO. 33:902-906. Author weblink DOI.
  • Ambrosin V; Nani C; Pettinato C; Fini M; D'Errico A; Trepidi S; Spinelli A; Al-Nahhas A; et alRubello D; Zompatori M; Fabbri M; Franchi R; Fanti S. (1 Aug 2007). Assessment of a chemically induced model of lung squamous cell carcinoma in mice by F-18-FDG small-animal PET. NUCLEAR MEDICINE COMMUNICATIONS. 28:647-652. Author weblink DOI.
  • Gross MD; Avram A; Fig LM; Fanti S; Al-Nahhas A; Rubello D. (1 Sep 2007). PET in the diagnostic evaluation of adrenal tumors. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 51:272-283. Author weblink.
  • Win Z; Al-Nahhas A; Rubello D; Gross MD. (1 Sep 2007). Somatostatin receptor PET imaging with Gallium-68 labeled peptides. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 51:244-250. Author weblink.
  • Liberatore M; Calandri E; Pavoni GL; Baiocchi P; Iurilli AP; Venditti M; Al-Nahhas A; Rubello D. (1 Jun 2007). Reliability of white blood cell scan in the follow-up of osteomyelitis. BIOMEDICINE & PHARMACOTHERAPY. 61:272-276. Author weblink DOI.
  • Dei Rossi F; Cracco E; Rampin L; Al-Nahhas A; Muzzio R; Rubello D. (1 Jun 2007). An unusual case of a solitary pulmonary nodule associated with an abscess correctly distinguished by Pet/Ct fusion imaging. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 26:287-289. Author weblink.
  • Khan S; Win Z; Lloyd CR; Neriman D; Szyszko TA; Svensson WE; Al-Nahhas A. (2007). Acrometastasis to the foot: an unusual presentation of transitional cell carcinoma of the bladder. Nucl Med Rev Cent East Eur. 10:26-28.
  • Al-Nahhas A; Win Z; Szyszko T; Singh A; Khan S; Rubello D. (Dec 2007). What can gallium-68 PET add to receptor and molecular imaging?. Eur J Nucl Med Mol Imaging. 34:1897-1901. DOI.
  • Coker RK; Ind PW; Hughes JMB; Myers M; Al Nahhas A; Frank J. (2002). Functional imaging of disease in sarcoidosis. Nucl Med Commun. 4, 23:399.
  • Smith S; Al Nahhas A; Vivian G. (2002). Value of I-123 MIBG as part of multimodality imaging in screening families with multiple endocrine neoplasia type 2A syndrome. World J Nucl Med. 1, 1:61-67.
  • Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; et alPelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S. (Aug 2007). Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology. Nucl Med Commun. 28:589-595. DOI.
  • Rubello D; Gross MD; Mariani G; Al-Nahhas A. (1 Jun 2007). Scintigraphic techniques in primary hyperparathyroidism: from pre-operative localisation to intra-operative imaging. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 34:926-933. Author weblink DOI.
  • Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; et alAlavi A; Fanti S. (Jul 2007). Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies. Nucl Med Commun. 28:547-553. DOI.
  • Al-Nahhas A; Win Z; Al-Sayed Y; Khan S; Singh A; Rubello D; Gishen P. (Sep 2007). Anatomic and functional imaging in the management of lymphoma. Q J Nucl Med Mol Imaging. 51:251-259.
  • Pelizzo MR; Boschin IM; Toniato A; Piotto A; Pagetta C; Gross MD; Al-Nahhas A; Rubello D. (Jun 2007). Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients. Clin Nucl Med. 32:440-444. DOI.
  • Tunariu N; Gibbs SJ; Win Z; Gin-Sing W; Graham A; Gishen P; Al-Nahhas A. (May 2007). Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med. 48:680-684. DOI.
  • Tehranipour N; AL-Nahhas A; Canelo R; Stamp G; Woo K; Tait P; Gishen P. (May 2007). Concordant F-18 FDG PET and Y-90 Bremsstrahlung scans depict selective delivery of Y-90-microspheres to liver tumors: confirmation with histopathology. Clin Nucl Med. 32:371-374. DOI.
  • Nanni C; Rubello D; Khan S; Al-Nahhas A; Fanti S. (Jun 2007). Role of small animal PET in stimulating the development of new radiopharmaceuticals in oncology. Nucl Med Commun. 28:427-429. DOI.
  • Ambrosini V; Tomassetti P; Rubello D; Campana D; Nanni C; Castellucci P; Farsad M; Montini G; et alAl-Nahhas A; Franchi R; Fanti S. (Jun 2007). Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours. Nucl Med Commun. 28:473-477. DOI.
  • Jiao LR; Szyszko T; Al-Nahhas A; Tait P; Canelo R; Stamp G; Wasan H; Lowdell C; et alPhilips R; Thillainayagam A; Bansi D; Rubello D; Limongelli P; Woo K; Habib NA. (Jun 2007). Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours. Eur J Surg Oncol. 33:597-602. DOI.
  • Win Z; Al-Nahhas A; Towey D; Todd JF; Rubello D; Lewington V; Gishen P. (May 2007). 68Ga-DOTATATE PET in neuroectodermal tumours: first experience. Nucl Med Commun. 28:359-363. DOI.
  • Kenny L; Coombes RC; Vigushin DM; Al-Nahhas A; Shousha S; Aboagye EO. (Sep 2007). Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography. Eur J Nucl Med Mol Imaging. 34:1339-1347. DOI.
  • Rubello D; Nanni C; Boschin IM; Toniato A; Piotto A; Rampin L; Mariani G; Al-Nahhas A; et alPelizzo MR. (1 Dec 2006). Sentinel lymph node (SLN) procedure with patent V blue dye in 153 patients with papillary thyroid carcinoma (PTC): Is it an accurate staging method?. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 25:483-486. Author weblink.
  • Liberatore M; Al-Nahhas A; Rubello D. (Mar 2007). White blood cell scan in the follow-up of infectious diseases: is the withdrawal of antibiotic therapy necessary?. Nucl Med Commun. 28:151-153. DOI.
  • Rubello D; Pelizzo MR; Al-Nahhas A; Salvatori M; O'Doherty MJ; Giuliano AE; Gross MD; Fanti S; et alSandrucci S; Casara D; Mariani G. (1 Nov 2006). The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma. EJSO. 32:917-921. Author weblink DOI.
  • Szyszko T; Al-Nahhas A; Canelo R; Habib N; Jiao L; Wasan H; Pagou M; Tait P. (Jan 2007). Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography. Nucl Med Commun. 28:15-20. DOI.
  • Szyszko T; Al-Nahhas A; Tait P; Rubello D; Canelo R; Habib N; Jiao L; Wasan H; et alBansi D; Thillainayagam A; Nijran K; Stamp G; O'Rourke E. (Jan 2007). Management and prevention of adverse effects related to treatment of liver tumours with 90Y microspheres. Nucl Med Commun. 28:21-24. DOI.
  • Nanni C; Rubello D; Castellucci P; Farsad M; Franchi R; Rampin L; Gross MD; Al-Nahhas A; et alFanti S. (1 Nov 2006). F-18-FDG PET/CT fusion imaging in paediatric solid extracranial tumours. BIOMEDICINE & PHARMACOTHERAPY. 60:593-606. Author weblink DOI.
  • Rubello D; Massaro A; Cittadin S; Rampin L; Al-Nahhas A; Boni G; Mariani G; Pelizzo MR. (1 Sep 2006). Role of Tc-99-sestamibi SPECT in accurate selection of primary hyperparathyroid patients for minimally invasive radio-guided surgery. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 33:1091-1094. DOI.
  • Nanni C; Rubello D; Al-Nahhas A; Fanti S. (Sep 2006). Clinical PET in oncology: not only FDG. Nucl Med Commun. 27:685-688. DOI.
  • Rubello D; Mariani G; Al-Nahhas A; Pelizzo MR; Italian Study Group on Radioguided Surgery and Immunoscintigraphy (GISCRIS). (Sep 2006). Minimally invasive radio-guided parathyroidectomy: long-term results with the 'low 99mTc-sestamibi protocol'. Nucl Med Commun. 27:709-713. DOI.
  • Webb M; Al-Nahhas A. (1 Jul 2006). Molecular imaging of Takayasu's arteritis and other large-vessel vasculitis with F-18-FDG PET. NUCLEAR MEDICINE COMMUNICATIONS. 27:547-549. Author weblink DOI.
  • Win Z; O'Flynn E; O'Rourke EJ; Singh A; Cooke GS; Friedland JS; Al-Nahhas A. (Jul 2006). F-18 FDG PET in the diagnosis and monitoring of salmonella vertebral osteomyelitis: a comparison with MRI. Clin Nucl Med. 31:437-440. DOI.
  • Singh A; Al-Nahhas A; Win Z. (Jun 2006). Current practice in pancreatic imaging: the role of nuclear medicine. Nucl Med Commun. 27:477-480.
  • Win Z; Rahman L; Murrell J; Todd J; Al-Nahhas A. (1 Apr 2006). The possible role of Ga-68-DOTATATE PET in malignant abdominal paraganglioma. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 33:506-506. Author weblink DOI.
  • Cooke GS; Cooke FJ; Stone M; Turner K; Al-Nahhas A; Win Z; Wain J; Rogers TR; et alFriedland JS; Bamford KB. (1 Jun 2006). Deep-seated resistance in relapsed paratyphoid fever. Clin Infect Dis. 42:e92-e94. DOI.
  • Tehranipour N; Al-Nahhas A; Towey DJ. (2005). Combination of physical exercise and adenosine improves accuracy of automatic calculation of stress LVEF in gated SPECT using QGS software. Nucl Med Rev Cent East Eur. 8:90-92.
  • Win Z; Todd J; Al-Nahhas A; Svensson WE. (Feb 2006). Superior vena cava obstruction as suggested by extrapulmonary uptake on lung scintigraphy. Clin Nucl Med. 31:99-100.
  • Win Z; O'Rourke E; Todd J; Al-Nahhas A; Svensson W; Frank J. (Jan 2006). Vesico-colic fistula as demonstrated by [18F]FDG-PET. Eur J Nucl Med Mol Imaging. 33:107. DOI.
  • Win Z; Todd J; Al-Nahhas A. (Oct 2005). FDG-PET imaging in Pneumocystis carinii pneumonia. Clin Nucl Med. 30:690-691.
  • Kenny LM; Vigushin DM; Al-Nahhas A; Osman S; Luthra SK; Shousha S; Coombes RC; Aboagye EO. (1 Nov 2005). Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods. Cancer Res. 65:10104-10112. DOI.
  • Allen S; Todd J; Copley S; Al-Nahhas A. (Jun 2005). F-18 FDG uptake in bilateral pulmonary artery leiomyosarcomata, one mimicking a pulmonary embolus. Clin Nucl Med. 30:418-419.
  • Popadic S; Al-Nahhas A; Naili Q; Todd J; Meeran K. (Apr 2005). Changes in the expression of somatostatin receptor imaging following Y-90 lanreotide therapy for carcinoid tumor: a flare response?. Clin Nucl Med. 30:238-240.
  • AL-Nahhas A. (Sep 2004). Dedifferentiated thyroid carcinoma: the imaging role of 18F-FDG PET and non-iodine radiopharmaceuticals. Nucl Med Commun. 25:891-895.
  • Andrews J; Al-Nahhas A; Pennell DJ; Hossain MS; Davies KA; Haskard DO; Mason JC. (Aug 2004). Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis. 63:995-1000. DOI.
  • Webb M; Chambers A; AL-Nahhas A; Mason JC; Maudlin L; Rahman L; Frank J. (May 2004). The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging. 31:627-634. DOI.
  • Malik IS; Harare O; AL-Nahhas A; Beatt K; Mason J. (Mar 2003). Takayasu's arteritis: management of left main stem stenosis. Heart. 89:e9.
  • Al-Nahhas AM. (2003). FDG PET and alternative imaging in the management of thyroid carcinoma. Nucl Med Rev Cent East Eur. 6:139-145.
  • Al-Nahhas A; Padhy A. (Sep 2002). Symposium on therapeutic intervention in nuclear medicine--an introduction. Nucl Med Commun. 23:827-828.
  • Hadi A; Al-Nahhas A; Vivian G; Hickling P. (Apr 2002). Tc-99m MDP and Tc-99m MIBI in the assessment of spondyloarthritis presenting as bone metastasis before treatment with infliximab. Clin Nucl Med. 27:297-298.
  • Hadi A; Hickling P; Brown M; Al-Nahhas A. (Jan 2002). Scintigraphic evidence of effect of infliximab on disease activity in ankylosing spondylitis. Rheumatology (Oxford). 41:114-116.

Conferences

  • Marks NA; Svensson WE; West S; Burton J; Al-Nahhas AM; Ind PW. Comparison of regional ventilatory and perfusion defects in severe chronic obstructive pulmonary disease. Winter Meeting of the British-Thoracic-Society/British-Lung-Foundation (BTS/BLF), 6 Dec 2006 - 8 Dec 2006. 61:II110-II110. B M J PUBLISHING GROUP (1 Dec 2006). Author weblink.
  • Sotiropoulos G; Li J; Al-Nahhas A; Spalding D; Tedeschi M; Carroll RW; Bockisch A. The Impact of 68Ga-DOTATOC PET/CT on the Multimodal Management of Patients with Neuroendocrine Tumors. 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease, 9 Mar 2011 - 11 Mar 2011. 94:45-45. KARGER (1 Jan 2011).
  • Joharatnam J; Carroll RW; Ghaffar A; Al-Nahhas A; Meeran K; Todd JF. Paraganglioma: Gallium-68 DOTATATE PET CT Scanning, a Useful Addition to MIBG Scanning in Metastatic Disease. 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease, 9 Mar 2011 - 11 Mar 2011. 94:29-30. KARGER (1 Jan 2011). Author weblink.
  • Carroll RW; Comminos A; Frilling A; Meeran K; Al-Nahhas A; Todd JF. Gallium-68 DOTATATE PET CT Frequently Changes Patient Management or Staging when Compared with Indium-111 Octreotide in the Assessment of Neuroendocrine Tumors. 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease, 9 Mar 2011 - 11 Mar 2011. 94:19-19. KARGER (1 Jan 2011). Author weblink.
  • Carroll RW; Tan T; Todd JF; Al-Nahhas A; Bomanji J; Gaze MN; Meeran K; Goldstone AP. Lutetium-177 DOTATATE Therapy in the Management of Neuroendocrine Tumors. 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease, 9 Mar 2011 - 11 Mar 2011. 94:19-19. KARGER (1 Jan 2011). Author weblink.
  • Carroll RW; Martin JL; Tan T; Goldstone AP; Spalding D; Al-Nahhas A; Todd JF; Meeran K; et alFrilling A. Primary Lymph Node Gastrinoma: A Genuine Entity? Two Case Reports and a Review of the Literature. 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease, 9 Mar 2011 - 11 Mar 2011. 94:18-19. KARGER (1 Jan 2011). Author weblink.
  • Towey DJ; Bain PG; Al-Nahhas A; Nijran KS. Data lead classification of 123I Ioflupane Images. Annual Congress of the European Association of Nuclear Medicine, 10 Oct 2009. op189.
  • Zerizer I; Barwick T; Tait P; Khan S; Towey D; Al-nahhas A. The role of (18)FDG-PET/CT and contrast enhanced CT in response assessment post intra-arterial (90)Yttrium SIR-Spheres therapy: comparison between SUV and Hounsefield unit. 23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), 9 Oct 2010 - 13 Oct 2010. 37:S279-S279. SPRINGER (1 Oct 2010). Author weblink.
  • Gulliver N; Murrell J; Wallis W; Al-Nahhas A. The Extended Role of the Nuclear Medicine Technologist in the UK: A New Perspective. 23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), 9 Oct 2010 - 13 Oct 2010. 37:S482-S482. SPRINGER (1 Oct 2010).
  • Naji M; Patel N; Mok W; Nijran K; Al-Nahhas A; Win Z. Radiotherapy Planning in Lung Cancer: How Accurately Can PET/CT Define Gross Tumour Volume?. 23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), 9 Oct 2010 - 13 Oct 2010. 37:S258-S258. SPRINGER (1 Oct 2010).
  • Naji M; Mok W; Patel N; Khan S; Win Z; Svensson W; Al-Nahhas A. Technical and clinical factors predicting delay or failure to localise sentinel lymph nodes in patients with breast cancer. 23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), 9 Oct 2010 - 13 Oct 2010. 37:S418-S418. SPRINGER (1 Oct 2010).
  • Vyas NS; Patel NH; Nijran KS; Puri BK; Al-Nahhas A. Positron Emission Tomography Neuroimaging in Schizophrenia: Current and Future Avenues. 23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), 9 Oct 2010 - 13 Oct 2010. 37:S389-S389. SPRINGER (1 Oct 2010).
  • Zerizer I; Al-Nahhas A; Mok W; Win Z. Evaluation of the role of dacrocystography vs lacrimal scintigraphy in patients with functional nasolacrimal obstruction. 23rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), 9 Oct 2010 - 13 Oct 2010. 37:S232-S232. SPRINGER (1 Oct 2010).
  • Amin A; Todd JF; Martin NM; Al-Nahhas A; Meeran K. Catrinoid heart disease presenting in a patient undergoing Lutetium-177 DOTATATE therapy. 18th International Symposium on Regulatory Peptides, 5 Sep 2010 - 8 Sep 2010. 164:14-15. ELSEVIER SCIENCE BV (9 Sep 2010). DOI.
  • Wasan H; Gungor H; Medani H; Soomal R; Charles W; Maurice S; Gary M; al-Nahhas A; et alNijran K; Tait P. SURVIVAL OF METASTATIC COLORECTAL CANCER PATIENTS TREATED WITH CONCURRENT Y90 CHEMO-RADIOEMBOLISATION (SIRT plus MODIFIED FOLFOX) AFTER FAILURE OF ALL LINES OF CONVENTIONAL THERAPY. 12th World Congress on Gastrointestinal Cancer, 30 Jun 2010 - 3 Jul 2010. 21:81-81. OXFORD UNIV PRESS (1 Jan 2010). Author weblink.
  • Chhina N; Tan T; Ramachandran R; Goldstone AP; Palazzo F; Al-Nahhas A; Todd JF; Meeran K. Debulking surgery prior to (177)Lutetium-DOTATATE therapy in management of metastatic bronchial carcinoid. 18th International Symposium on Regulatory Peptides, 5 Sep 2010 - 8 Sep 2010. 164:15-15. ELSEVIER SCIENCE BV (9 Sep 2010). DOI.
  • Kenny LM; Coombes RC; Contractor K; Stebbing J; Al-Nahhas A; Palmieri C; Shousha S; Lowdell C; et alAboagye E. [11C]Choline-PET imaging of breast cancer. 45th Annual Meeting of the American-Society-of-Clinical-Oncology, 29 May 2009 - 2 Jun 2009. 27. AMER SOC CLINICAL ONCOLOGY (20 May 2009).
  • Kenny LM; Contractor K; Stebbing J; Al-Nahhas A; Palmieri C; Shousha S; Aboagye EO; Coombes RC. Changes in [F-18]Fluorothymidine Pharmacokinetics Following Capecitabine Treatment in Human Breast Cancer Detected by Positron Emission Tomography. 32nd Annual San Antonio Breast Cancer Symposium, 9 Dec 2009 - 13 Dec 2009. 69:765S-765S. AMER ASSOC CANCER RESEARCH (15 Dec 2009).
  • Khodjibekova M; Al-Nahhas A; Rasulova N; Myasnik B; Pirnazarov M. Myocardial perfusion scintigraphy in assessment of results of CABG in patients with IHD. 20th Annual Congress of the European-Association-of-Nuclear-Medicine. 34:S274-S275. (Oct 2007).
  • Singh A; Hart JL; Khan S; Szyszko T; Pillay N; Nijran KS; Al-Nahhas A. Clinical significance of adrenal uptake with Ga-68-DOTA-octreotate PET imaging. 20th Annual Congress of the European-Association-of-Nuclear-Medicine. 34:S192-S192. (Oct 2007).
  • Paolini R; Rampin L; Banti E; Fanti S; Al-Nahhas A; Rubello D. FDG-PET/CT detection of primary bone marrow large b-cell lymphoma in a patient with hairy cell leukemia. 20th Annual Congress of the European-Association-of-Nuclear-Medicine, 2007. 34:S386-S386. SPRINGER (1 Oct 2007). Author weblink.
  • Chapman HR; Towey DJ; Al-Nahhas A; Nadarajah J; Nijran KS. Have you reviewed the way you process your Gated Blood Pool Studies and are your ejection fractions reliable?. 20th Annual Congress of the European-Association-of-Nuclear-Medicine, 2007. 34:S339-S339. SPRINGER (1 Oct 2007). Author weblink.
  • Szyszko T; Duprez O; Frank J; Svensson W; Al-Nahhas A. Incidence of positive bone scans and low prostate specific antigen levels: Comparison with published recommendations. 20th Annual Congress of the European-Association-of-Nuclear-Medicine, 2007. 34:S310-S310. SPRINGER (1 Oct 2007). Author weblink.
  • Khan S; Duprez O; Szyszko T; Singh A; Shah S; Win Z; Khojibekova M; Murrell J; et alAl-Nahhas A. Gallium-68 DOTATOC PET Imaging in neuroendocrine and neuroectodermal tumours: The value of multimodality imaging. 20th Annual Congress of the European-Association-of-Nuclear-Medicine, 2007. 34:S297-S297. SPRINGER (1 Oct 2007). Author weblink.
  • Szyszko T; Tait P; Khan S; Singh A; Duprez O; Nijran K; Al-Nahhas A. Yttrium-90 microspheres in liver tumours: Effects of extrahepatic disease. 20th Annual Congress of the European-Association-of-Nuclear-Medicine, 2007. 34:S137-S137. SPRINGER (1 Oct 2007). Author weblink.
  • Rahman ML; Shiner RJ; Jones HA; Clark I; Ind PW; Al-Nahhas A. How does wholebody PET imaging using (FLT)-F-18 compare to (18)FDG in the detection of brain metastases and is there diagnostic value of additional delayed high count zoomed brain scans?. Annual Congress of the European-Association-of-Nuclear-Medicine. 31:S400-S400. (Aug 2004).
  • Naili Q; Todd J; Mullen K; Al-Nahhas A. Can imaging with 111In-Octreotide replace 111In-Lanreotide in the first pre-therapy scan in patients with known neuroendocrine liver metastasis? "Preliminary results". Annual Congress of the European-Association-of-Nuclear-Medicine. 31:S357-S357. (Aug 2004).
  • Kenny LM; Al-Nahhas A; Vigushin D; Coombes RC; Aboagye EO. [F-18]Fluorothymidine retention in breast cancer measured by PET - Initial results from a pilot study. Annual Congress of the European-Association-of-Nuclear-Medicine. 31:S328-S328. (Aug 2004).
  • Kenny LM; Coombes RC; Al-Nahhas A; Osman S; Lowdell C; Aboagye E. A feasibility study of [C-11]choline for the molecular imaging of human breast cancer in vivo using positron emission tomography (PET). 42nd Annual Meeting of the American-Society-of-Clinical-Oncology. 24:31S-31S. (20 Jun 2006).
  • Kenny LM; Aboagye EO; Al-Nahhas A; Charles L; Coombes RC. [C-11]choline-PET in human breast cancer: utility, reproducibility and effect of receptor tyrosine kinase inhibition by trastuzumab. 29th Annual San Antonio Breast Cancer Symposium. 100:S212-S212. (Jan 2006).
  • Kenny L; Al-Nahhas A; Shousha S; Osman S; Vigushin DM; Coombes RC; Aboagye EO. Determination of [F-18]fluorothymidine kinetics in tumour and normal tissues of patients with breast cancer using positron emission tomography. British Cancer Research Meeting 2004, 27 Jun 2004 - 30 Jun 2004. 91:S44-S44. NATURE PUBLISHING GROUP (1 Jul 2004). Author weblink.
  • Malik LS; Al-Nahhas A; Peters AM; Haskard DO. Imaging musculoskeletal infection with (111)indium labeled anti-E-selectin monoclonal antibody 1.2B6 as an alternative to (111)indium labeled leukocyte scintigraphy. 68th Annual Scientific Meeting of the American-College-of-Rheumatology/39th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, 16 Oct 2004 - 21 Oct 2004. 50:S263-S263. WILEY-LISS (1 Sep 2004). Author weblink.
  • Kenny LM; Vigushin DM; Coombes RC; Osman S; Shousha S; Al-Nahhas A; Aboagye E. Early assessment of response to treatment in breast cancer by [F-18]fluorathymidine-positron emission tomography. 41st Annual Meeting of the American-Society-of-Clinical-Oncology, 13 May 2005 - 17 May 2005. 23:155S-155S. AMER SOC CLINICAL ONCOLOGY (1 Jun 2005). Author weblink.
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook